Lung ultrasound during newborn resuscitation predicts the need for surfactant therapy in very- and extremely preterm infants
Shiraz Badurdeen, C. Omar F. Kamlin, Sheryle Rogerson, Stefan C. Kane, Graeme R. Polglase, Stuart B. Hooper, Peter G. Davis, Douglas A. Blank
Abstract
INTRODUCTION: Early identification of infants requiring surfactant therapy improves outcomes. We evaluated the accuracy of delivery room lung ultrasound (LUS) to predict surfactant therapy in very- and extremely preterm infants. METHODS: threshold of 0.3 to predict subsequent surfactant therapy. RESULTS: weeks with LUS test positive received surfactant. Twenty-six infants (50%) had worsening of LUS grades on serial assessment. CONCLUSIONS: weeks.
Topics & Concepts
MedicineResuscitationLung ultrasoundSurfactant therapyPulmonary surfactantUltrasoundIntensive care medicineLungNeonatal resuscitationEmergency medicineInternal medicineRadiologyGestational agePregnancyThermodynamicsGeneticsBiologyPhysicsUltrasound in Clinical ApplicationsNeonatal Respiratory Health ResearchCongenital Diaphragmatic Hernia Studies